# EDGAR Filing Document

**Accession Number:** 0001835579
**File Stem:** 9999999995-25-001888
**Filing Date:** 2025-6
**Character Count:** 1269
**Document Hash:** 55ca5b86fd3b2caa81c06037289098f2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-25-001888.hdr.sgml**: 20250612

**ACCESSION NUMBER**: 9999999995-25-001888

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250611

**DATE AS OF CHANGE**: 20250612

**EFFECTIVENESS DATE**: 20250611

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ikena Oncology, Inc.
- **CENTRAL INDEX KEY:** 0001835579
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-285881
- **FILM NUMBER:** 251041565

**BUSINESS ADDRESS:**
- **STREET 1:** 50 NORTHERN AVE.
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 857-343-8292

**MAIL ADDRESS:**
- **STREET 1:** 50 NORTHERN AVE.
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** June 11, 2025

**Time:** 16:15:00

**Form Type:** S-4

---

**CIK:** 0001835579

**Company Name:** Ikena Oncology, Inc.

**File Number:** 333-285881